New jersey

Index
Globenewswire

AUSTEDO® (deutetrabenazine) Tablets and AUSTEDO XR® (deutetrabenazine) Extended-release Tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

Globenewswire

Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis

Globenewswire

Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy

Globenewswire

MISTRAS Group Partnering with Villari to Offer Wireless Crack-Detection Sensors for Critical Steel Assets

Globenewswire

FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder

Globenewswire

Verisk Names Saurabh Khemka President of Underwriting Solutions

Globenewswire

Patients Taking AUSTEDO XR® (deutetrabenazine) Extended-release Tablets Reported Symptom Improvement and High Satisfaction

Globenewswire

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-'749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Globenewswire

AvePoint Announces Dual Listing on the Singapore Exchange to Continue Global Expansion

Globenewswire

AvePoint Announces Pricing of Public Offering

Globenewswire

Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology and Venerology Congress

Berita

Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy

Globenewswire

$152 Billion and Rising: New Report Shows Insurance Industry Facing Growing Average Annual Losses from Natural Catastrophes

Globenewswire

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss

Globenewswire

Boehringer Ingelheim and Palatin Technologies to Develop Potential First-in-class Melanocortin Receptor Targeted Treatment for Patients with Retinal Diseases

Globenewswire

FDA Approves Expanded Indication for AJOVY® (fremanezumab-vfrm), The First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

Globenewswire

Verisk Signs Definitive Agreement to Acquire AccuLynx

Globenewswire

Impulse Dynamics® Completes Enrollment of Pivotal Trial for CCM-D® HF System and Earns Category 1 CPT Codes for CCM® Therapy

Globenewswire

Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate

Globenewswire

Synchronoss Meraih Sertifikasi Kerangka Privasi Data UE-A.S.

Globenewswire

Synchronoss Achieves EU-U.S. Data Privacy Framework Certification

Globenewswire

KLOG Transport Solutions Delivers Cargo Visibility Across Europe Powered by ORBCOMM® Satellite IoT Technology

Globenewswire

Spring Bio Solution Meluncurkan NCE Grid untuk Mendekode Peluang Pengajuan Para IV dan First-to-File

Globenewswire

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

Globenewswire

ORBCOMM® Launches CrewView to Enable Smart Containers to Fill the Last Gap in End-to-end Visibility While at Sea